Resources

This fact sheet outlines PATH's pneumococcal vaccine project from a technical perspective. It includes an overview of PATH's vaccine development portfolio and partners to support the development of vaccines against pneumonia and other pneumococcal diseases that can be effective and affordable for children in the developing world.

During the early years of life, growth faltering due to undernutrition has both immediate and lifelong consequences for human health and development. In this brief, we examine systematic reviews and meta-analyses that investigate the impacts of selected underlying, nutrition-sensitive risk factors on stunted linear growth.

Market assessment and recommendations to increase access to oxygen and pulse oximetry in Indonesia

PATH and partners issue a statement with new data showing the devastating human cost of proposed Administration cuts to foreign assistance.

From 2014 to 2016, PATH coordinated pilot introduction of the injectable contraceptive subcutaneous DMPA (DMPA-SC, brand name Sayana® Press) in Burkina Faso, Niger, Senegal, and Uganda. These materials feature guidance for monitoring DMPA-SC introductions, monitoring results, and lessons learned, which can help inform contraceptive introduction programming for DMPA-SC and other methods. For more information, visit DMPA-SC: Expanding contraceptive access and options or email FPoptions@path.org.